Biogen, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Biogen, Inc. (Biogen or 'the company') discovers, develops, manufactures and commercializes therapies in the areas of hematology, neurology and immunology. The company develops therapies for multiple sclerosis, neuroimmunology movement disorders, including Parkinson's disease, Alzheimer’s disease and dementia, and neuromuscular disorders, including amyotrophic lateral sclerosis and spinal muscular atrophy. It also develops and manufactures biosimilars of advanced biologics. The company markets its products under Flixabi, Benepali, Imraldi, Spinraza, Tecfidera, Avonex, Tysabri, Eylea, Gazyva, Fampyra, Plegridy and Fumaderm brand names. Biogen has business operations in the US, Asia and Europe. The company is headquartered in Weston, Massachusetts, the US.Scope
- Detailed information on Biogen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
- Intelligence on Biogen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Biogen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Biogen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Biogen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Biogen, Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Biogen, Inc.: Company Overview
- Biogen, Inc.: Overview and Key Facts
- Biogen, Inc.: Overview
- Biogen, Inc.: Key Facts
- Biogen, Inc.: Key Employees
- Biogen, Inc.: Key Employee Biographies
- Biogen, Inc.: Major Products and Services
- Biogen, Inc.: Management Statement
- Biogen, Inc.: Key Competitors
- Biogen, Inc.: Company Analysis
- Biogen, Inc.: Business Description
- Biogen, Inc.: SWOT Analysis
- Biogen, Inc.: SWOT Overview
- Biogen, Inc.: Strengths
- Biogen, Inc.: Weaknesses
- Biogen, Inc.: Opportunities
- Biogen, Inc.: Threats
- Biogen, Inc.: Corporate Financial Deals Activity
- Biogen, Inc.: Financial Deals Overview
- Biogen, Inc.: Targets and Partners
- Biogen, Inc.: Top Deals 2019 - 2023YTD*
- Biogen, Inc.: Advisors
- Biogen, Inc.: Top Legal Advisors
- Biogen, Inc.: Top Financial Advisors
- Biogen, Inc.: Mergers and Acquisitions
- Biogen, Inc.: Corporate Venturing
- Biogen, Inc.: Capital Raising
- Biogen, Inc.: Partnership
- Biogen, Inc.: Divestments
- Biogen, Inc.: Recent Developments
- Biogen, Inc.: News and Events Summary
- Biogen, Inc.: Business Expansion
- Biogen, Inc.: Corporate Governance
- Biogen, Inc.: Financial Performance
- Biogen, Inc.: Market Developments
- Biogen, Inc.: Research & Development
- Biogen, Inc.: Strategy and Operations
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
Table 1: Biogen, Inc.: Key Facts
Table 2: Biogen, Inc.: Key Employees
Table 3: Biogen, Inc.: Key Competitors
Table 4: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Biogen, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 6: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Table 7: Biogen, Inc.: Targets and Partners
Table 8: Biogen, Inc.: Top Deals 2019 - 2023YTD*
Table 9: Biogen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Biogen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Biogen, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 12: Biogen, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Table 13: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 14: Biogen, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 15: Biogen, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 16: Biogen, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 17: Biogen, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 18: Biogen, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 19: Biogen, Inc.: Divestments by Geography (2019 - YTD*2023)
Table 20: Biogen, Inc.: News and Events Summary
Table 21: Biogen, Inc.: Business Expansion
Table 22: Biogen, Inc.: Corporate Governance
Table 23: Biogen, Inc.: Financial Performance
Table 24: Biogen, Inc.: Market Developments
Table 25: Biogen, Inc.: Research & Development
Table 26: Biogen, Inc.: Strategy and Operations
List of Figures
Figure 1: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Biogen, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 3: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Biogen, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 5: Biogen, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 6: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 7: Biogen, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 8: Biogen, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 9: Biogen, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 10: Biogen, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 11: Biogen, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 12: Biogen, Inc.: Divestments by Geography (2019 - YTD*2023)
